Author

Yi‐Pei Hung

Observed name: Yi-Pei Hung

Institutions: Lumtec (Taiwan), Taiwan AI Labs

Observed institutions: Lumtec (Taiwan), Taiwan AI Labs

ORCID: 0000-0002-3546-6615

Observed ORCID: 0000-0002-3546-6615

OpenAlex ID: A5001896744

Treatment of knee osteoarthritis with intra-articular injection of allogeneic adipose-derived stem cells (ADSCs) ELIXCYTE®: a phase I/II, randomized, active-control, single-blind, multiple-center clinical trial

2021 · Cheng-Fong Chen, Chih-Chien Hu, et al. · Stem Cell Research & Therapy · 91

Allogeneic adipose tissue‐derived stem cells ELIXCYTE® in chronic kidney disease: A phase I study assessing safety and clinical feasibility

2022 · Cai‐Mei Zheng, I‐Jen Chiu, et al. · Journal of Cellular and Molecular Medicine · 18

A novel therapeutic approach for endometriosis using adipose-derived stem cell-derived conditioned medium- A new hope for endometriotic patients in improving fertility

2023 · S. Joseph Huang, Chun-Yen Huang, et al. · Frontiers in Endocrinology · 11

ELIXCYTE®, an Allogenic Adipose-Derived Stem Cell Product, Mitigates Osteoarthritis by Reducing Inflammation and Preventing Cartilage Degradation In Vitro

2024 · Yu-Hsiu Chen, Yi-Pei Hung, et al. · Current Issues in Molecular Biology · 3

Real‐World Data as External Control in Assessing the Efficacy of Allogeneic Adipose‐Derived Stem Cells Therapy for Advanced Chronic Kidney Disease

2025 · Yi‐Chun Lin, Yi‐Pei Hung, et al. · Clinical and Translational Science · 2

Clinical efficacy and safety of allogeneic adipose-derived stem cells ELIXCYTE in chronic kidney disease: a phase I/II study

2025 · Yi-Chun Lin, Yi-Pei Hung, et al. · Stem Cells Translational Medicine

Works count: 6

Citation count: 125

H-index: 3

I10-index: 3